191 related articles for article (PubMed ID: 35018247)
1. Depletion of tumor suppressor miRNA-148a in plasma relates to tumor progression and poor outcomes in gastric cancer.
Komatsu S; Imamura T; Kiuchi J; Takashima Y; Kamiya H; Ohashi T; Konishi H; Shiozaki A; Kubota T; Okamoto K; Otsuji E
Am J Cancer Res; 2021; 11(12):6133-6146. PubMed ID: 35018247
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-148a suppresses tumor cell invasion and metastasis by downregulating ROCK1 in gastric cancer.
Zheng B; Liang L; Wang C; Huang S; Cao X; Zha R; Liu L; Jia D; Tian Q; Wu J; Ye Y; Wang Q; Long Z; Zhou Y; Du C; He X; Shi Y
Clin Cancer Res; 2011 Dec; 17(24):7574-83. PubMed ID: 21994419
[TBL] [Abstract][Full Text] [Related]
3. microRNA-148a suppresses human gastric cancer cell metastasis by reversing epithelial-to-mesenchymal transition.
Wang SH; Li X; Zhou LS; Cao ZW; Shi C; Zhou CZ; Wen YG; Shen Y; Li JK
Tumour Biol; 2013 Dec; 34(6):3705-12. PubMed ID: 23873106
[TBL] [Abstract][Full Text] [Related]
4. Low plasma levels of miR-101 are associated with tumor progression in gastric cancer.
Imamura T; Komatsu S; Ichikawa D; Miyamae M; Okajima W; Ohashi T; Kiuchi J; Nishibeppu K; Kosuga T; Konishi H; Shiozaki A; Okamoto K; Fujiwara H; Otsuji E
Oncotarget; 2017 Dec; 8(63):106538-106550. PubMed ID: 29290969
[TBL] [Abstract][Full Text] [Related]
5. Low levels of tumour suppressor miR-655 in plasma contribute to lymphatic progression and poor outcomes in oesophageal squamous cell carcinoma.
Kiuchi J; Komatsu S; Imamura T; Nishibeppu K; Shoda K; Arita T; Kosuga T; Konishi H; Shiozaki A; Okamoto K; Fujiwara H; Ichikawa D; Otsuji E
Mol Cancer; 2019 Jan; 18(1):2. PubMed ID: 30609933
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-148a is downregulated in gastric cancer, targets MMP7, and indicates tumor invasiveness and poor prognosis.
Sakamoto N; Naito Y; Oue N; Sentani K; Uraoka N; Oo HZ; Yanagihara K; Aoyagi K; Sasaki H; Yasui W
Cancer Sci; 2014 Feb; 105(2):236-43. PubMed ID: 24283384
[TBL] [Abstract][Full Text] [Related]
7. Depleted tumor suppressor miR-107 in plasma relates to tumor progression and is a novel therapeutic target in pancreatic cancer.
Imamura T; Komatsu S; Ichikawa D; Miyamae M; Okajima W; Ohashi T; Kiuchi J; Nishibeppu K; Konishi H; Shiozaki A; Morimura R; Ikoma H; Ochiai T; Okamoto K; Taniguchi H; Otsuji E
Sci Rep; 2017 Jul; 7(1):5708. PubMed ID: 28720759
[TBL] [Abstract][Full Text] [Related]
8. Expression and prognostic value of microRNA-26a and microRNA-148a in gastric cancer.
Qiu X; Zhu H; Liu S; Tao G; Jin J; Chu H; Wang M; Tong N; Gong W; Zhao Q; Qiang F; Zhang Z
J Gastroenterol Hepatol; 2017 Apr; 32(4):819-827. PubMed ID: 27529338
[TBL] [Abstract][Full Text] [Related]
9. LncRNA HOXA11-AS promotes migration and invasion through modulating miR-148a/WNT1/β-catenin pathway in gastric cancer.
Guo T; Yuan X; Liu DF; Peng SH; Xu AM
Neoplasma; 2020 May; 67(3):492-500. PubMed ID: 32009419
[TBL] [Abstract][Full Text] [Related]
10. Restoration of miRNA-148a in pancreatic cancer reduces invasion and metastasis by inhibiting the Wnt/β-catenin signaling pathway via downregulating maternally expressed gene-3.
Sun Y; Zhu Q; Zhou M; Yang W; Shi H; Shan Y; Zhang Q; Yu F
Exp Ther Med; 2019 Jan; 17(1):639-648. PubMed ID: 30651845
[TBL] [Abstract][Full Text] [Related]
11. Validation of circulating miRNA biomarkers for predicting lymph node metastasis in gastric cancer.
Kim SY; Jeon TY; Choi CI; Kim DH; Kim DH; Kim GH; Ryu DY; Lee BE; Kim HH
J Mol Diagn; 2013 Sep; 15(5):661-9. PubMed ID: 23806809
[TBL] [Abstract][Full Text] [Related]
12. Decreased expression of microRNA-148a predicts poor prognosis in ovarian cancer and associates with tumor growth and metastasis.
Gong L; Wang C; Gao Y; Wang J
Biomed Pharmacother; 2016 Oct; 83():58-63. PubMed ID: 27470550
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-148a suppresses the epithelial-mesenchymal transition and metastasis of hepatoma cells by targeting Met/Snail signaling.
Zhang JP; Zeng C; Xu L; Gong J; Fang JH; Zhuang SM
Oncogene; 2014 Jul; 33(31):4069-76. PubMed ID: 24013226
[TBL] [Abstract][Full Text] [Related]
14. miR-148a suppresses cell invasion and migration in gastric cancer by targeting DNA methyltransferase 1.
Shi H; Chen X; Jiang H; Wang X; Yu H; Sun P; Sui X
Oncol Lett; 2018 Apr; 15(4):4944-4950. PubMed ID: 29541249
[TBL] [Abstract][Full Text] [Related]
15. MiR-148a suppressed cell invasion and migration via targeting WNT10b and modulating β-catenin signaling in cisplatin-resistant colorectal cancer cells.
Shi L; Xi J; Xu X; Peng B; Zhang B
Biomed Pharmacother; 2019 Jan; 109():902-909. PubMed ID: 30551544
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-148a-3p inhibits cancer progression and is a novel screening biomarker for gastric cancer.
Bao C; Guo L
J Clin Lab Anal; 2020 Oct; 34(10):e23454. PubMed ID: 32785967
[TBL] [Abstract][Full Text] [Related]
17. microRNA-33a prevents epithelial-mesenchymal transition, invasion, and metastasis of gastric cancer cells through the Snail/Slug pathway.
Chen DD; Cheng JT; Chandoo A; Sun XW; Zhang L; Lu MD; Sun WJ; Huang YP
Am J Physiol Gastrointest Liver Physiol; 2019 Aug; 317(2):G147-G160. PubMed ID: 30943047
[TBL] [Abstract][Full Text] [Related]
18. Circulating microRNA-203 predicts metastases, early recurrence, and poor prognosis in human gastric cancer.
Imaoka H; Toiyama Y; Okigami M; Yasuda H; Saigusa S; Ohi M; Tanaka K; Inoue Y; Mohri Y; Kusunoki M
Gastric Cancer; 2016 Jul; 19(3):744-53. PubMed ID: 26233325
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-148a-3p inhibits progression of hepatocelluar carcimoma by repressing SMAD2 expression in an Ago2 dependent manner.
Huang Z; Wen J; Yu J; Liao J; Liu S; Cai N; Liang H; Chen X; Ding Z; Zhang B
J Exp Clin Cancer Res; 2020 Aug; 39(1):150. PubMed ID: 32746934
[TBL] [Abstract][Full Text] [Related]
20. Regulation of aberrantly expressed SERPINH1 by antitumor miR-148a-5p inhibits cancer cell aggressiveness in gastric cancer.
Kawagoe K; Wada M; Idichi T; Okada R; Yamada Y; Moriya S; Okubo K; Matsushita D; Arigami T; Kurahara H; Maemura K; Natsugoe S; Seki N
J Hum Genet; 2020 Aug; 65(8):647-656. PubMed ID: 32235846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
